Article info
Coronary artery disease
Original article
Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention
- Correspondence to Professor Stefan K James, Department of Medical Sciences, Cardiology, Uppsala University, Uppsala Clinical Research Center, Dag Hammarskjölds väg 14B 752 37 Uppsala stefan.james{at}ucr.uu.se
Citation
Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention
Publication history
- Received November 5, 2015
- Revised December 23, 2015
- Accepted December 30, 2015
- First published February 4, 2016.
Online issue publication
March 23, 2016
Article Versions
- Previous version (4 February 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/